Micro-X Ltd. (OTC:MCRXF) Filings

Micro-X Ltd.

Filings

FilingDateTypeFiled with
MX1 - 2026 AGM Results of MeetingNov 11, 2026Meeting outcomeASX
Change in substantial holdingNov 11, 2026Ownership change noticeASX
MX1 - Quarterly Results PresentationNov 3, 2026Quarterly reportASX
MX1 - Quarterly Activities Report & Appendix 4COct 29, 2026Quarterly reportASX
MX1 - Quarterly Activities Report & Appendix 4COct 29, 2026Quarterly reportASX
MX1 - Notice Under Section 708A(5) of the Corporations ActOct 23, 2026Other filingsASX
Application for quotation of securities - MX1Oct 23, 2026FinancingASX
Notification of cessation of securities - MX1Oct 23, 2026FinancingASX
MX1 - Notice of 2026 Annual General Meeting and Proxy FormOct 14, 2026Meeting noticeASX
Change of Director's Interest Notice - Patrick O'BrienOct 8, 2026Ownership change noticeASX
Change of Director's Interest Notice - Andrew HartmannOct 8, 2026Ownership change noticeASX
Change of Director's Interest Notice - Jim McDowellOct 8, 2026Ownership change noticeASX
Change of Director's Interest Notice - Ilona MeyerOct 8, 2026Ownership change noticeASX
Notification regarding unquoted securities - MX1Oct 8, 2026Other filingsASX
MX1 - Convertible Note Funding UpdateOct 8, 2026FinancingASX
MX1 - Results of MeetingSep 28, 2026Meeting outcomeASX
MX1 - DHS CT Baggage Scanner Contract ExtensionSep 27, 2026Other filingsASX
MX1 - Change of Director's Interest Notice - Patrick O'BrienSep 24, 2026Ownership change noticeASX
Response to ASX Price QuerySep 23, 2026Explanation requestASX
MX1 - Investor Open Day Presentation RecordingSep 9, 2026Other filingsASX
Notification of cessation of securities - MX1Sep 9, 2026FinancingASX
MX1 - Notice Under Section 708A(5) of the Corporations ActSep 9, 2026Notification letterASX
Application for quotation of securities - MX1Sep 9, 2026FinancingASX
Ceasing to be a substantial holderSep 3, 2026Ownership change noticeASX
MX1 - 2026 Appendix 4E and Annual ReportAug 27, 2026Annual reportASX
MX1 - Notice of General Meeting and Proxy FormAug 27, 2026Meeting noticeASX
MX1 - 2026 Appendix 4G and Corporate Governance StatementAug 27, 2026Other filingsASX
MX1 - Investor Open DayAug 18, 2026Meeting noticeASX
Notification of cessation of securities - MX1Aug 14, 2026FinancingASX
MX1 - Notice Under Section 708A(5) of the Corporations ActAug 14, 2026Other filingsASX
Application for quotation of securities - MX1Aug 14, 2026FinancingASX
MX1 - Notice Under Section 708A(5) of the Corporations ActAug 12, 2026FinancingASX
Notification regarding unquoted securities - MX1Aug 12, 2026Other filingsASX
Change in substantial holdingAug 6, 2026Ownership change noticeASX
MX1 - Investor PresentationAug 2, 2026Other filingsASX
MX1 - Management Update & Convertible Note IssueAug 2, 2026FinancingASX
Proposed issue of securities - MX1Aug 2, 2026FinancingASX
MX1 - Quarterly Activities Report & Appendix 4CJul 31, 2026Quarterly reportASX
MX1 - Micro-X Completes Full Body CT Critical Design ReviewJun 9, 2026Other filingsASX
MX1 - Human Imaging Study Commences with Micro-X Head CTJun 2, 2026Operations updateASX
$1.3m Checkpoint Contract Extension Awarded by DHSMay 18, 2026Other filingsASX
MX1 - First Full Body CT Laboratory Test Bench CompletedMar 9, 2026Operations updateASX
MX1 - December 2025 Half Year Results PresentationFeb 26, 2026Interim reportASX
MX1 - Appendix 4D and Half Year Financial StatementsFeb 26, 2026Interim reportASX
MX1 - Response to Publication on Government WebsiteFeb 22, 2026Other filingsASX
MX1 - Head CT First Human Pilot Site at Royal MelbourneFeb 3, 2026Operations updateASX
MX1 - Quarterly Activities Report & Appendix 4CJan 29, 2026Quarterly reportASX
MX1 - $6m Capital Raising PresentationDec 17, 2025FinancingASX
MX1 - $6.18m PlacementDec 17, 2025FinancingASX
Trading HaltDec 15, 2025Trading halt or suspensionASX
MX1 - Micro-X Receives $5.1 Million R&D Tax IncentiveOct 6, 2025Other filingsASX
MX1 - $3.3M Rover Plus Order from Malaysian MOHOct 2, 2025Acquisition or disposalASX
MX1 - Head CT Milestone - Proceeding to Imaging TrialSep 30, 2025Operations updateASX
MX1 - $2.5M Checkpoints Contract Extension with DHSSep 23, 2025Other filingsASX
MX1 - $4.4M IGP Grant Received for Head CTSep 23, 2025Operations updateASX
MX1 - 2025 Full Year Results PresentationAug 27, 2025ResultsASX
MX1 - 2025 Appendix 4E and Annual ReportAug 27, 2025Annual reportASX
MX1 - Supply Agreement with Major US Healthcare ProviderJul 29, 2025Acquisition or disposalASX
MX1 - Micro-X Achieves $2.3m of Development MilestonesJun 16, 2025Other filingsASX
MX1 - Appendix 4C and Quarterly Activities StatementApr 28, 2025Quarterly reportASX
MX1 - Result of Entitlement OfferMar 19, 2025FinancingASX
MX1 - December 2024 Half Year Results PresentationFeb 28, 2025Interim reportASX
MX1 - Appenxix4D and Half Year Financial StatementsFeb 28, 2025Interim reportASX
MX1 - Extension of Retail Entitlement OfferFeb 24, 2025Offer documentASX
MX1 - $6.0M DHS Contract ExtensionFeb 13, 2025Other filingsASX
MX1 - Retail Offer BookletFeb 12, 2025Offer documentASX
MX1 - $2.7M Retail Offer OpensFeb 12, 2025FinancingASX
MX1 - $3.3M raised through Placement and Institutional OfferFeb 9, 2025FinancingASX
Reinstatement to Official QuotationFeb 9, 2025Trading halt or suspensionASX
MX1 - $6M Capital RaiseFeb 6, 2025FinancingASX
MX1 - $5.6M Strategic PartnershipFeb 5, 2025Other filingsASX
Voluntary SuspensionFeb 3, 2025Trading halt or suspensionASX
MX1 - Quarterly Cash Flows and Activities StatementJan 31, 2025Quarterly reportASX
MX1 - $6.4M R&D Incentive receivedDec 5, 2024ResultsASX
MX1 - Portable Full Body CT Decvelopment AgreementDec 3, 2024Operations updateASX
MX1 - US Government Development ContractDec 3, 2024Other filingsASX
Pause in TradingDec 2, 2024Trading halt or suspensionASX
MX1 - 2024 AGM Chair's AddressNov 12, 2024Other filingsASX
MX1 - 2024 AGM - CEO PresentationNov 12, 2024Other filingsASX
MX1 - 2024 Full Year Results PresentationAug 28, 2024ResultsASX
MX1 - 2024 Appendix 4E and Annual ReportAug 28, 2024Annual reportASX
MX1 - Results of Share Purchase PlanMay 27, 2024FinancingASX
MX1 - Quarterly Cash Flow and Activities StatementApr 28, 2024Quarterly reportASX
MX1 - Prospectus lodgementApr 24, 2024Offer documentASX
Micro-X completes $4M Placement and announces SPPApr 16, 2024FinancingASX
MX1 - December 2023 Half Year Results PresentationFeb 27, 2024Interim reportASX
MX1 - Appendix 4D & Half Year Financial StatementsFeb 27, 2024Interim reportASX
MX1 - Quarterly Cashflows and Activity StatementJan 29, 2024Quarterly reportASX
MX1 - Rover receives CE Mark certificationOct 26, 2023Operations updateASX
MX1 - Receipt of $6.2M R&D Tax RebateOct 22, 2023ResultsASX
MX1 - $1.5M Rover order from Australian GovernmentSep 19, 2023Operations updateASX
MX1 - Appendix 4E and Annual Financial StatementsAug 29, 2023Annual reportASX
MX1 - Strategy Refresh PresentationAug 6, 2023Other filingsASX
MX1 - DHS Airport Security Contract - up to $21MJul 23, 2023Other filingsASX
Response to ASX QueryMay 30, 2023Explanation requestASX
MX1 - Leadership Transition - Kingsley Hall appointed CEOMay 1, 2023Other filingsASX
MX1 - Quarterly Cash Flow and Activities ReportApr 26, 2023Quarterly reportASX
MX1 - 2022 AGM CEO PresentationNov 14, 2022Other filingsASX
MX1 - 2022 AGM Chairs AddressNov 14, 2022Other filingsASX
MX1 - Quarterly Cashflow and Activities StatementOct 25, 2022Quarterly reportASX
MX1 - DHS Contract Extensions AwardedSep 25, 2022Other filingsASX
MX1 - $15M Strategic Investment and CollaborationSep 19, 2022Other filingsASX
Mx1 - Amended Auditors ReportSep 2, 2022Other filingsASX
MX1 - Appendix 4E and 2022 Annual Financial ReportAug 29, 2022Annual reportASX
MX1 - Amended Quarterly Cash Flows and Activity ReportAug 1, 2022Quarterly reportASX
MX1 - Appointment of second major US DistributorJun 13, 2022Other filingsASX
MX1 - Appendix 4D and Half Yearly ReportFeb 23, 2022Interim reportASX
MX1 - Amended Quarterly Cash Flows and Activities StatementJan 27, 2022Quarterly reportASX
MX1 - Receipt of $2.1M R&D RebateDec 21, 2021Other filingsASX
MX1 - US Govt DHS Baggage X-ray Development contract signedSep 29, 2021Other filingsASX
MX1 - US Govt DHS Airport Security Portal contract signedSep 29, 2021Other filingsASX
MX1 - $8M contract signed with Australian Stroke AllianceSep 23, 2021Other filingsASX
MX1 - Rover receives ARTG listingSep 13, 2021Other filingsASX
MX1 - Appendix 4E and 2021 Annual Financial ReportAug 26, 2021Annual reportASX
MX1 - Rover FDA approval opens US Healthcare MarketMay 25, 2021Other filingsASX
MX1 Quarterly Cash Flows and Activity StatementApr 12, 2021Quarterly reportASX
MX1 - Market Update - Thales Settlement and IED X-ray cameraMar 15, 2021Other filingsASX
MX1 - Successful MRFF Funding AwardFeb 28, 2021Other filingsASX
MX1 - Appendix 4D and Half Year Financial ReportFeb 24, 2021Interim reportASX
Micro-X - SPP Offer OpenFeb 3, 2021Other filingsASX
Micro-X completes $30.5M Placement and announces SPPJan 31, 2021FinancingASX
MX1 Quarterly Activities and Cash Flow ReportJan 19, 2021Quarterly reportASX
MX1 - Receipt of $1.95M R&D RebateJan 7, 2021Other filingsASX
MX1 - $1.3M Rover contract with Australia Defence ForceDec 17, 2020Other filingsASX
Micro-X Amended Nano Distribution AgreementNov 18, 2020Other filingsASX
Market Update DHS US$4M Airport Security AwardNov 3, 2020Other filingsASX
Micro-X Quarterly Cash Flow and Activities StatementOct 21, 2020Quarterly reportASX
Micro-X Market update - First Sale of RoverSep 30, 2020Other filingsASX
Appendix 4E and 2020 Annual Financial ReportAug 27, 2020Annual reportASX
Appendix 4C - quarterlyJul 21, 2020Quarterly reportASX
Micro-X Receives Rover FDA 510(k) ApprovalJul 19, 2020Other filingsASX
Micro-X Market Update - Submission of Rover FDA 510 (k)Jun 10, 2020Other filingsASX
Market update - Micro-X Rover Testing CompleteJun 1, 2020Other filingsASX
Micro - X - Nano shipment and reduction in backlogMay 29, 2020Other filingsASX
Micro-X Market Update Nano Production IncreasingMay 12, 2020Other filingsASX
Micro-X Results of Entitlement OfferMay 11, 2020FinancingASX
Micro-X - $15M Placement & Underwritten Entitlement OfferApr 17, 2020FinancingASX
Non Renounceable Entitlement Offer ProspectusApr 16, 2020FinancingASX
Quarterly Activities & Cash Flow ReportApr 7, 2020Quarterly reportASX
Market UpdateMar 25, 2020Other filingsASX
Appendix 4D & Half-Year Financial ReportFeb 13, 2020Interim reportASX
Quarterly Cash Flow & Business UpdateJan 30, 2020Quarterly reportASX
Lodgement of ProspectusNov 19, 2019Offer documentASX
Micro-X $16.5M Private PlacementNov 18, 2019FinancingASX
MARKET UPDATENov 15, 2019Other filingsASX
Suspension from Official QuotationNov 5, 2019Trading halt or suspensionASX
CARBON NANOTUBE EMITTER PATENT PUBLISHEDOct 20, 2019Other filingsASX
UK Government Follow-On Airport Security ContractSep 5, 2019Other filingsASX
Appendix 4E and 2019 Annual ReportAug 30, 2019Annual reportASX
Federal Court Orders GrantedJul 25, 2019Legal or regulatory actionASX
Next Generation Proprietary CNT X-ray Tubes InsourcedJul 14, 2019Other filingsASX
COMPLETION OF $10M INVESTMENT BY THALES SAJul 2, 2019Other filingsASX
Cleansing NoticeMay 28, 2019FinancingASX
Trading haltMay 23, 2019Trading halt or suspensionASX
Pause in tradingMay 22, 2019Trading halt or suspensionASX
MICRO-X SIGNS ALLIANCE WITH THALES GROUPMar 31, 2019Other filingsASX
Appendix 4D and Half-Year Financial ReportFeb 28, 2019Interim reportASX
COMPLETION OF CAPITAL RAISEDec 24, 2018Other filingsASX
SUCCESSFUL COMPLETION OF $3.0M CAPITAL RAISEOct 1, 2018Other filingsASX
R&D Tax RebateSep 17, 2018Other filingsASX
Appendix 4E and 2018 Annual ReportAug 29, 2018Annual reportASX
EXPECTED IMPAIRMENT CHARGE CLARIFICATIONAug 15, 2018Other filingsASX
EXPECTED IMPAIRMENT CHARGEAug 13, 2018Other filingsASX
R&D CONTRACT SIGNED WITH UK MINISTRY OF DEFENCEApr 26, 2018Other filingsASX
SUCCESSFUL COMPLETION OF $5.0M CAPITAL RAISINGMar 27, 2018FinancingASX
NANO COMMERCIALISATION UPDATEMar 6, 2018Other filingsASX
Appendix 4D and Half Year Financial ReportFeb 28, 2018Interim reportASX
Nano Commercialisation - First From Production AcceptanceOct 4, 2017Other filingsASX
Appendix 4E and 2017 Annual ReportAug 30, 2017Annual reportASX
R&D TAX REBATEAug 29, 2017Other filingsASX
Carestream receives FDA 510(k) Approval for NanoJun 25, 2017Other filingsASX
SUCCESSFUL COMPLETION OF $4.8M ENTITLEMENT OFFERMay 5, 2017FinancingASX
Micro-X Entitlement Offer now fully underwrittenApr 12, 2017FinancingASX
Entitlement OfferApr 9, 2017FinancingASX
Nano Commercialisation Update - K number received from FDAMar 14, 2017Other filingsASX
Nano Commercialisation Update - ISO 13485 AccreditationMar 5, 2017Other filingsASX
Nano Commercialisation UpdateNov 27, 2016Other filingsASX
Appendix 4E and 2016 Annual ReportAug 31, 2016Annual reportASX
Micro-X & Carestream Sign Development and Supply AgreementsAug 28, 2016Other filingsASX
Micro-X makes US$4 Million Investment in Xinray Systems Inc.Feb 11, 2016Other filingsASX
ASX Market Release - Admission to Official ListFeb 10, 2016Other filingsASX